Reneuron Share Discussion Threads

[lauders] 16/4/2019 14:58

OK JBJ. I can see where your statement came from although the links aren't showing. If it is proactive investors the links are blocked. Need to find on youtube or show with a few dots between the two words so can copy and paste and then remove the dots. Will check the comments you share out. Cheers.

[jensonbensonjohnson] 16/4/2019 14:53

It's speculation, Lauders, yes, but ...

After the April 4th efficacy RNS, Michael Hunt said this: "[...] even though the announcement itself is really more of a *teaser* for data we will be formally presenting in conference in Vancouver at the end of this month"

[

Said within first 30 seconds here:

[...]

]

He's always been straight up; for him to have said that is a really strong indicator of good news to come.

Directors/insiders have bought substantial numbers of shares at 225p.

They've been given incentives directly related to doubling the share price from these levels. They must believe that's realistic.

I've been following RENE for 15+ years and I feel it's changed fundamentally now. I feel very confident that the rises we've seen so far are really just the tip of the iceberg.

[bg23] 16/4/2019 14:26

as mentioned previously, I am a small holder of these.

I was talking to a friend who is more scientifically aware than myself about RENE and the recent optical test results.

his immediate comment was that it is possible that the stem cell treatment may show additional improvement over and above the initial improvement over a longer time period.

scientifically I suppose this is possible? does anyone have a real insight in this respect?

I'm not sure this possibility is being discussed, but if it occurred at any level, ongoing improvement would be even more of a gamechanger - wouldn't it?

[eggy6198] 16/4/2019 14:22

Plus further deals on pipeline japan wss mentioned in coropate prestention on the company website.... that china deal had huge potential over the 80 million in royailites. Must expect these shorters to appesr but is much more thsn 50 50 the next updste isnt it. Will truely expolde then! Take over target in the future and no need for cash. This is a medium term gold mine so dont let shorters rob you

[philh75] 16/4/2019 13:48

Lauders,

50p or 250p it is still undervalued from a market cap perspective given that they have signed a £80m deal for China and likely to sign a similar size deal for the US.

[lauders] 16/4/2019 13:29

Do you have any reason to state that JBJ or is it just "speculation"? RENE have shot up almost vertical since 50p so profit taking/consolidation is expected. We don't know whether the update on 26th WILL be good or not, we just all hope it will be, especially when it comes to the patients!

[jensonbensonjohnson] 16/4/2019 13:10

Prepare for an almighty bounce

[volsung] 16/4/2019 12:57

You pop up like a rash david

[verger] 16/4/2019 12:56

And prior to that it had been well oversold. The question is what is it worth? Huge potential in my view.

[masingi] 16/4/2019 11:18

Letmepass- they have just signed a marketing deal with a major Chinese pharma company, funding isn't an issue for the foreseeable anymore.

[letmepass] 16/4/2019 10:46

Alot of publicity. Usually a sign of major fundraise

[masingi] 16/4/2019 08:41

It's very difficult predicting when to sell because the dips are so short and then it shoots up to new highs. Particularly when the share is so undervalued compared to broker estimates.
I sold at 70p and bought back in at £1.00 (oops). It just moves so fast!

[volsung] 16/4/2019 08:19

Bought a few more on the mini dip. Is that you out completely now tt?

[top tips] 16/4/2019 08:16

Timed my exit nicely.

[someuwin] 15/4/2019 14:28

Further read-outs from the patients treated in the Phase 1/2 study will be presented at the 6(th) Annual Retinal Cell and Gene Therapy Innovation Summit, taking place in Vancouver, Canada, on 26 April 2019. Information regarding this conference may be found at:



The Company will make a further announcement later this month, when these further read-outs from the study are known.

The Company's RP clinical programme benefits from Orphan Drug Designation in both Europe and the US, as well as Fast Track designation from the FDA.

[hollywood6] 15/4/2019 14:21

It's a big conference and I am expecting good news going into it. Director buys and share options all suggest it will be

[hollywood6] 15/4/2019 14:20

Hopefully early news on the second patient cohort also

[pdt] 15/4/2019 13:59

The first patient of the cohort was treated mid December 2018 I believe so they should be having a four month follow-up about now ?? The other two must have had their two month follow-ups.

If I read the release correctly they will announce as soon as these results are known. I assume the headline information could come any day with the detail announced at the conference on the 26th April.

Interesting times :)

[volsung] 15/4/2019 13:30

I'm in STX. Its doing ok but not as well as SUMM, MTFB or MTPH to be honest

[78steve] 15/4/2019 13:18

Have any of the holders here had a look at STX share price on the rise the company is awaiting US approval for product dealing with iron deficiency. Price said to double on confirmation. Dyor

[dennisbergkamp] 15/4/2019 11:47

It’s nice to make some dosh along the way, but super happy the company’s actually making a difference to people’s health.

D

[verger] 15/4/2019 11:37

Sentiment turning favourable on much better future visibility.

[macmoss] 15/4/2019 08:13

Same article in The Mail on Sunday.

[lauders] 15/4/2019 03:28

Some more press from the weekend. Admittedly, "only" the Express but it gets the word out there and hopefully it if the beginning of a lot of hope that develops into a lot of good news for people who can be helped with their eyesight down the road. Then we can all hope the same will happen to stroke patients.